Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

L-ergothioneine (MitoPrime)

L-Ergothioneine (EGT) · also known as Ergothioneine, EGT, MitoPrime, King of longevity vitamins

L-ergothioneine is a sulfur-containing amino acid derivative that cells take up through the OCTN1 transporter. Oral absorption has been confirmed in human studies. Its direct free-radical scavenging, mitochondrial protection and anti-inflammatory effects in humans have not been confirmed.

Typical dose: Standard L-ergothioneine: 5–10 mg/day, taken with a meal
Absorption and forms: The OCTN1 transporter is found in tissues such as bone marrow, liver, kidney and some neurons. Expression is not prominent in mature red blood cells. Oral absorption is confirmed in human studies, but tissue retention time cannot be uniformly described as several months.

Clinical uses and human evidence

Sleep quality

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Okumura 2025 · Food Sci Nutr · RCT · n=128 — Estimation and Validation of an Effective Ergothioneine Dose for Improved Sleep Quality Using Physiologically Based Pharmacokinetic Model
  2. Zajac 2025 · Nutraceuticals · RCT · n=147 — The Effect of Ergothioneine Supplementation on Cognitive Function, Memory, and Sleep in Older Adults with Subjective Memory Complaints: A Randomized Placebo-Controlled Trial

Memory

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Zajac 2025 · Nutraceuticals · RCT · n=147 — The Effect of Ergothioneine Supplementation on Cognitive Function, Memory, and Sleep in Older Adults with Subjective Memory Complaints: A Randomized Placebo-Controlled Trial
  2. Yau 2024 · J Alzheimers Dis · RCT · n=19 — Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study

Age-related cognitive decline

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Yau 2024 · J Alzheimers Dis · RCT · n=19 — Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study

Mechanisms of action

Direct free radical trapping and chemical quenching

★★☆☆☆Mechanism evidence: grade DPrimary target

L-ergothioneine is taken up into cells through the OCTN1 transporter. In vitro, it can bind metal ions such as iron and copper, and it can react with oxidants. Whether it directly scavenges free radicals in humans after oral intake has not been confirmed with any mechanism-specific marker.

References (2)
  1. Cheah et al. 2017 · Human randomized trial: 5 or 25 mg/day can raise body ergothioneine levels; short-term oxidative damage markers did not show a clear improvement
  2. 2014 · Human endothelial cell study: OCTN1 mediated uptake and reduced experimental oxidative damage

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★☆☆☆Mechanism evidence: grade DSecondary target

Cell studies suggest that L-ergothioneine can modulate NF-κB/p65-related inflammatory responses, and bone protection was seen in animal oral studies. However, a drop in inflammatory mediators does not equal NF-κB inhibition, and the effect at usual human doses is not established.

References (2)
  1. Li et al. 2026 · Mouse and cell study: oral mouse model showed bone protection; cell experiments suggest NF-κB/p65 is involved
  2. Cheah et al. 2017 · Human randomized trial: human NF-κB inhibition not established

Mitochondrial electron transport chain carriers and oxidative phosphorylation coupling

★☆☆☆☆Mechanism evidence: grade DSecondary target

The protective effect of L-ergothioneine on mitochondria is still under study, but this does not mean it works as an electron carrier in the respiratory chain. No reliable study has shown that it transfers electrons between complexes. Human studies have only confirmed its uptake.

References (2)
  1. No direct study found · Literature search conclusion: no reliable study shows L-ergothioneine acting as an electron carrier between complex I/II and complex III
  2. Cheah et al. 2017 · Human randomized trial: oral uptake confirmed, but electron-transport-chain carrier function not measured

Safety and drug interactions

L-ergothioneine is not yet recognized as an essential vitamin. Short-term human studies show good tolerability, but this does not prove that long-term use is free of toxicity. Long-term safety still needs more data.
Open in the interactive app ›